🔗 Permalink

Inventor profile of:

Malcolm Hill

City:

Solana Beach, California

Country:

United States

Published Applications:

Last publication date:

2022-10-20

Top Assignees for applications by Malcolm Hill

The entities that hold a legal rights for patent applications filed by inventor Hill Malcolm:

Meritage Pharma, Inc. 12 San Diego, CA United States
Verus Pharmaceuticals, Inc. 12 San Diego, CA United States
The Regents of the University of California 5 Oakland, CA United States
MERITAGE PHARMA INC. 4 Lexington, MA United States
The Regents of the University of California, San Diego 2 La Jolla, CA United States
ViroPharma Biologics LLC 2 Lexington, MA United States

Recent patent applications by Hill Malcolm

Malcolm Hill from Solana Beach, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-10-20

US20220331242A1

Human necessities

TOPICAL CORTICOSTEROIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT

#2 | 2022-09-01

US20220273801A1

Human necessities

COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION

#3 | 2019-07-25

US20190224324A1

Human necessities

Compositions for the treatment of gastrointestinal inflammation

#4 | 2019-07-04

US20190201333A1

Human necessities

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

#5 | 2018-11-15

US20180325921A1

Human necessities

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT

#6 | 2018-03-15

US20180071211A1

Human necessities

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

#7 | 2016-08-18

US20160235769A1

Human necessities

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT

#8 | 2016-03-17

US20160078186A1

Physics

Systems, methods, and software for providing a patient-reported outcome measure of dysphagia patients with eosinophilic esophagitis

#9 | 2015-08-20

US20150231156A1

Human necessities

CORTICOSTEROID COMPOSITIONS

#10 | 2015-01-01

US20150005270A1

Human necessities

Compositions for the treatment of gastrointestinal inflammation

#11 | 2014-07-03

US20140187523A1

Human necessities

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

#12 | 2011-04-28

US20110097401A1

Human necessities

METHODS FOR TREATING GASTROINTESTINAL DISORDERS

#13 | 2010-08-26

US20100216754A1

Human necessities

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT

#14 | 2009-07-30

US20090191275A1

Human necessities

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

#15 | 2009-07-16

US20090181099A1

Human necessities

Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

#16 | 2009-06-04

US20090143343A1

Human necessities

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION OF THE GASTROINTESTINAL TRACT

#17 | 2009-05-28

US20090137540A1

Human necessities

Compositions for the treatment of gastrointestinal inflammation

#18 | 2009-05-14

US20090123551A1

Human necessities

GASTROINTESTINAL DELIVERY SYSTEMS

#19 | 2009-05-14

US20090123550A1

Human necessities

Corticosteroid compositions

#20 | 2009-05-14

US20090123390A1

Human necessities

COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION

#21 | 2008-01-24

US20080020003A1

Human necessities

Methods for the delivery of a beta2 agonist to induce bronchodilation and formulations for use in the same

#22 | 2007-12-20

US20070293582A1

Human necessities

Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms

#23 | 2007-12-20

US20070293581A1

Human necessities

Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies

#24 | 2007-12-20

US20070293580A1

Human necessities

Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies

#25 | 2007-11-29

US20070276048A1

Human necessities

UNIT DOSE FORMULATIONS COMPRISING AN INHALABLE SOLUTION OF ALBUTEROL

#26 | 2007-10-25

US20070249572A1

Human necessities

Systems and methods for the delivery of corticosteroids

#27 | 2007-08-23

US20070197487A1

Human necessities

Systems and methods for the delivery of corticosteroids having an increased lung deposition

#28 | 2007-08-23

US20070197486A1

Human necessities

Methods and systems for the delivery of corticosteroids

#29 | 2007-08-16

US20070191599A1

Human necessities

METHODS OF MANUFACTURING CORTISCOSTEROID SOLUTIONS

#30 | 2007-08-16

US20070191327A1

Human necessities

STERILIZATION OF CORTICOSTEROIDS WITH REDUCED MASS LOSS

#31 | 2007-08-16

US20070191323A1

Human necessities

STABLE CORTICOSTEROID MIXTURES

#32 | 2007-08-09

US20070185066A1

Human necessities

Systems and methods for the delivery of corticosteroids

#33 | 2007-08-02

US20070178050A1

Human necessities

Methods and systems for the delivery of corticosteroids having an increased lung depositon

#34 | 2007-08-02

US20070178049A1

Human necessities

Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile

#35 | 2007-07-12

US20070160542A1

Human necessities

Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile

InventorID:

824951 ⎘